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INTRODUCTION 
Prophylactic anticoagulation has been of paramount importan­
ce in preventing coronary ischemic events, stroke and peripheral 
arterial obstruction. Moreover, since the advent of coronary stenting, 
these drugs have become fundamental as adjuvants to this invasive 
ap proach to coronary disorders. Each year, anticoagulant therapy is 
used to protect millions of cardiac patients from direct artery obstruc­
tion or reocclusion after implanting a stent(1,2). On the other hand, it is 
well known that anticoagulated patients are exposed to a greater risk 
of hemorrhages when submitted to incisional surgeries(3).
ABSTRACT
Purpose: To investigate and describe, among the members of the Brazilian 
Glaucoma Society (BGS), the practices regarding the perioperative manage­
ment of anticoagulants (warfarin and aspirin) use in patients scheduled for 
glaucoma surgery. 
Methods: The active members of the Brazilian Glaucoma Society answered a 
questionnaire evaluating different aspects of their current perioperative mana­
gement of glaucomatous patients taking warfarin or aspirin.
Results: A total of 52 participants returned a complete questionnaire. Warfarin 
or aspirin was routinely interrupted prior to glaucoma surgery by 82.7% of the 
respondents. The majority of the surgeons who discontinued these medications 
reported doing so 7 days prior to surgery and resumed their use the day after the 
procedure. Almost half of our interviewees reported hemorrhagic complications 
that could be related to anticoagulant therapy. A large number of the surgeons 
(86.5%) preferred a particular surgical technique for anticoagulated patients; 
however, most of them (88.5%) do not change the anesthetic planning in such 
patients. Finally, the majority of the participants (90.4%) refer their anticoagulated 
patients to a preoperative appointment with a cardiologist or a general practitioner 
before the surgery.
Conclusions: The majority of Brazilian Glaucoma Society members participating in 
this study interrupt either warfarin or aspirin prior to glaucoma surgery. Although 
there is scant information available in the literature to offer definitive guidance, 
most participants from the Brazilian Glaucoma Society seem to share the same 
opinion when it comes to perioperative management of anticoagulant users.
Keywords: Anticoagulants/adverse effects; Aspirin; Warfarin; Glaucoma/surgery; 
Cataract extraction; Perioperative period; Societies, medical; Questionnaires
RESUMO
Objetivo: Investigar e descrever, entre os membros da Sociedade Brasileira de Glaucoma 
(SBG), as práticas relativas ao manejo de anticoagulantes (varfarina e aspirina) em 
pacientes agendados para cirurgia antiglaucomatosa.
Métodos: Foi enviado um questionário objetivo aos membros ativos da Sociedade 
Brasileira de Glaucoma avaliando diferentes aspectos da forma como conduzem seus 
pacientes em uso de varfarina ou aspirina durante o período perioperatório de uma 
cirurgia antiglaucomatosa.
Resultados: Cinquenta e dois participantes retornaram o questionário preenchido 
adequadamente. O uso de varfarina ou aspirina foi rotineiramente interrompido antes 
da cirurgia antiglaucomatosa por 82,7% dos entrevistados. A maior parte dos cirurgiões, 
quando interromperam o uso destes medicamentos, o fez sete dias antes da cirurgia 
e os reintroduziram no dia seguinte ao procedimento. Aproximadamente metade 
dos entrevistados disse ter observado complicações hemorrágicas que poderiam ser 
relacionados à terapia anticoagulante. Embora a maioria dos cirurgiões (86,5%) referiu 
utilizar alguma técnica cirúrgica em particular para esses pacientes anticoagulados, 
quase todos (88,5%) não alteram seu planejamento anestésico de rotina nesses mes-
mos casos. Finalmente, a maior parte dos participantes (90,4%) relatou referir seus 
pacientes anticoagulados para uma avaliação pré-operatória com um cardiologista 
ou um clínico geral.
Conclusão: A maior parte dos membros da Sociedade Brasileira de Glaucoma que 
participou desse estudo refere interromper o uso de anticoagulantes (varfarina ou 
aspirina) antes de uma cirurgia antiglaucomatosa. Embora existam poucas infor-
mações disponíveis na literatura para oferecer uma orientação definitiva, a maioria 
dos participantes parece compartilhar da mesma opinião quando se trata do manejo 
perioperatório de anticoagulantes.
Descritores: Anticoagulantes/efeitos adversos; Aspirina; Varfarina; Glaucoma/cirurgia; 
Extração de catarata; Período perioperatório; Sociedades médicas; Questionários 
The general perioperative management of anticoagulated pa­
tients has been described previously in details(3). In ophthalmological 
surgeries, there are some data postulating the safety in maintaining 
anticoagulants before cataract surgery(3,4); however, there is little 
in formation available to offer definitive guidance in glaucoma sur­
gery(5), as well as in retina surgery(6). 
The purpose of the present study was to evaluate the current 
routine of glaucoma surgeons in Brazil regarding the use of anticoa­
gulants in patients scheduled for glaucoma surgery. The study was 
based on data collected from the members of the Brazilian Glauco­
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ma Society (BGS) and aimed to investigate different aspects of their 
perioperative management of glaucomatous patients taking two 
commonly used anticoagulants: warfarin and aspirin. 
METHODS
An email containing a 9­item questionnaire was adapted from a 
previous paper, which surveyed cataract surgeons facing anticoagula­
ted patients submitted to cataract surgery(7). The main data collected 
were the percentage of surgeons who routinely withhold warfarin or 
aspirin before surgery, the number of days prior to surgery that anticoa­
gulants are discontinued; as well as the number of days after surgery 
in which such drugs are resumed. Additional information included the 
frequency of complications associated either with the maintenance or 
the stopping of anticoagulants, possible changes in surgeon’s usual 
anesthesia procedure and need of preoperative appointment with a 
cardiologist or a general practitioner prior to surgery.
The questionnaire was sent by email to all ophthalmologists affi­
liated to the BGS. The survey was self administered and confidential, 
with no reminder letters sent. Even though there were 580 active 
members in the society at that time, approximately 30% could not be 
reached (due to full mailbox, wrong email address or Internet server 
issues). Replies were collected over 2 months. In the last BGS meeting, 
more specialists were stimulated to participate. All data were entered 
and analyzed in an Excel database, and descriptive analysis was used 
to summarize the results of the survey. Only full­filled questionnaires 
were considered for analysis. 
RESULTS
A total of 52 participants returned a complete questionnaire, 
resulting in a response rate of approximately 13%. 
When asking about interrupting anticoagulation drugs, 82.7% 
(42 out of 52) said they interrupted both aspirin and warfarin before 
operating on these patients, and the remaining 17.3% (9 out of 52) 
kept such medications throughout the perioperative period. Among 
those who interrupted anticoagulants, the majority (36 out of 52, 
corresponding to 69.2%) did so seven days before surgery, interrup­
ting both aspirin and warfarin. Three participants (5.8%) interrupted 
anticoagulants for 10 days, and one (1.9%) did so for 15 days. Finally, 
three (5.8%) suspended the drugs for up to 5 days before the pro­
cedure (Table 1). Regarding the participants who suspended the 
anticoagulants, most of them resumed such drugs in the following 
manner: 24 (55.8%) reintroduced the drugs 1 day after the procedure, 
4 (9.3%) after 2­5 days, and 9 (20.9%) after 7 days. 
Twenty­seven respondents (51.9%) experienced hemorrhagic 
complications that may have been related to anticoagulation thera­
py. There were participants who reported more than one hemorrha­
gic event. Among them, 8 (29.6%) reported the occurrence of exces­
sive subconjunctival hemorrhage (one of them noticed hemorrhage 
at the filtration bleb); 7 (25.9%) reported the occurrence of hyphema, 
8 (29.6%) described cases of increased postoperative bleeding and 
two (7.4%) reported a hemorrhagic choroidal detachment. There 
were three reports (11.1%) of hemorrhage related to the needle­ 
based eye block. 
Anticoagulation was not a reason for choosing a specific anes­
thetic planning to the vast majority of the surgeons, as 47 (90.4%) of 
them did not change their usual anesthesia procedure. According 
to the participants, 38 (73.1%) preferred injectable anesthesia while 
12 (23.1%) preferred topical anesthesia and only two (3.8%) chose 
general anesthesia. The surgical procedure itself can vary according 
to the presence of anticoagulants: 45 participants (86.5%) preferred 
a particular incision type in these patients, whereas 7 (13.5%) did 
not change their technique. Finally, the majority of the participants 
(90.3%) referred their anticoagulated patients to a preoperative ap­
pointment with a cardiologist or a general practitioner prior to the 
surgery. 
DISCUSSION 
The perioperative management of patients who require tempo­
rary interruption of vitamin K antagonists or antiplatelet drugs be­
cause of a surgical procedure is a common and challenging clinical 
problem(2). The number of such patients has increased over the last 
decade, due to cardiovascular diseases (atrial fibrillation, mechanical 
heart valve) or percutaneous coronary intervention; therefore, these 
patients are no longer the tiny minority of the non­cardiac surgical 
candidates. A multicenter audit has shown that 28.1% and 5.1% of 
48,862 patients submitted to cataract surgery were taking aspirin or 
warfarin, respectively(8). 
The rare occurrence of serious hemorrhagic complications with 
visual impairment in patients who keep aspirin or warfarin throughout 
the perioperative period has been shown before(7,9). An Evidence­ 
Based Clinical Practice Guideline suggested (a Grade 1C recommen­
dation) that patients undergoing cataract extraction who are under 
warfarin or aspirin should continue their anticoagulants around the 
time of the procedure(2). Anticoagulants were also advised to be 
maintained even in cases of 25­gauge vitrectomy, in which the fre­
quency of serious hemorrhagic complications were extremely low(10). 
Unfortunately, there are scant data available for such patients when 
it comes to glaucoma surgery. 
In a previous survey done in the United Kingdom, questionnaires 
were sent to ophthalmologists with a special interest in glaucoma(5). 
Approximately 30% of the respondents stop either warfarin or as­
pirin, for 4 and 7 days prior to surgery, respectively. These numbers 
are significantly lower when compared to the responses of most of 
the participants from our study, as over 80% are prone to interrupt 
both drugs, and most of them do so for seven days before surgery. 
We believe the main reason for this difference could be related to 
the fact that a significant percentage of the participants in our study 
(approximately half of them) have experienced hemorrhagic compli­
cations in their anticoagulated patients during or after a glaucoma 
surgery. Another interesting difference between these two studies is 
that while most of the interviewees in our study (over 90%) required 
a cardiologist or a general practitioner opinion when dealing with 
anticoagulated patients prior to glaucoma surgery (even though 
there is no official guideline for this), only 23.8% of the respondents 
from the British survey(5) usually rely on a second opinion (in fact, an 
hematologist was the specialist required in that study). 
We found that the majority of BGS members interviewed prefer­
red injectable anesthesia. A large study analyzed more than 14,000 
peribulbar/retrobulbar anesthesias in a cohort where 24.2% and 4% 
of the patients were on aspirin or warfarin, respectively. Hemorrhage 
rate in that study due to the anesthesia was found to be extremely 
low(4). However, as discussed previously, not only anesthesia related 
hemorrhages can occur in anticoagulated patients, but also those 
related to the surgical manipulation itself. The later seem to be even 
more important in these cases, as approximately half of the BGS 
members interviewed reported some type of hemorrhagic compli­
cation (from subconjunctival hemorrhage to choroidal detachment). 
In this context, a previous report have alerted to the risk of excessive 
Table 1. Routine anticoagulation management prior to glaucoma 
surgery
Anticoagulation management Percentage of participants 
Withhold treatment 10 days or more before surgery 07.7% (04/52)
Withhold treatment 7 days before surgery 69.2% (36/52)
Withhold treatment up to 5 days before surgery 05.8% (03/52)
Do not withhold anticoagulant therapy 17.3% (09/52)
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hemorrhage during glaucoma surgery in anticoagulated patients, 
es pecially in those taking warfarin(11). 
The main drawback of our paper is its low response rate (13%) and 
number of participants (n=52), which should be considered while 
interpreting our results. Looking carefully at the related literature, 
res ponse rates of ophthalmological surveys seem to vary significan­
tly. For instance, while a small survey among cataract surgeons in 
Singapore reported a response rate of 61%(12), a large study in the 
USA among the American Society of Cataract and Refractive Surgery 
(ASCRS) members had a much lower rate, of approximately 15%(13). 
Interestingly, the later study is a traditional survey, which had been 
applied and reported annually since 1985(14). We believe that different 
factors might have partially contributed to the low response rate we 
have obtained. First, glaucoma specialists in general could not be 
used to this type of surgical survey. While there are many previously 
published surgical surveys among cataract surgeons, a significant 
proportion of the surveys among glaucoma specialists have focused 
on the clinical management of the disease (drug preferences), and 
not on surgical preferences. Second, this type of study design is not 
a usual practice in Brazil, as there are few publications available in 
the ophthalmological literature based on questionnaire responses 
(surveys). In addition, some of the participants could not be familiar 
or even comfortable while dealing with an Internet based approa­
ch. Third, differently from cataract specialists, not every glaucoma 
specialist performs surgical procedures. We believe that a significant 
proportion of the BGS members might not be composed by active 
glaucoma surgeons. Finally, two other aspects or limitations of our 
study should be considered as they might have influenced our re­
sults. We assessed the management of anticoagulants considering 
warfarin and aspirin in conjunction. Therefore, we could not determi­
ne whether a respondent would have a different approach for each 
anticoagulant drug. In addition, due to the study design (Survey), 
glaucoma specialists that had previous hemorrhagic complications 
usually tend to participate more than those who never experienced 
such problems. This fact (bias) might have increased the percentage 
of hemorrhagic events reported in our study. 
CONCLUSION
In sum, the majority of the BGS members interviewed interrupt 
anticoagulant drugs before a glaucoma surgery. Most of the ophthal­
mologists withhold either warfarin or aspirin for seven days. Ninety 
percent require a cardiologist or a general practitioner opinion prior 
to the surgery. Hemorrhagic surgical complications were reported by 
approximately half of the interviewees. Currently, the management 
of anticoagulated patients scheduled for glaucoma surgery has no 
specific recommendation. Possibly, these patients are exposed to a 
higher risk, and further studies are necessary to establish a definitive 
medical management protocol. 
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